Screening for pancreatic neoplasia in high-risk individuals: An EUS-based approach

Marcia Irene Canto, Michael Goggins, Charles J. Yeo, Constance Griffin, Jennifer E. Axilbund, Kieran Brune, Syed Z. Ali, Sanjay Jagannath, Gloria M Petersen, Elliot K. Fishman, Steven Piantadosi, Francis M. Giardiello, Ralph H. Hruban

Research output: Contribution to journalArticle

334 Citations (Scopus)

Abstract

Background & Aims: Relatives of patients with pancreatic cancer and persons with certain inherited syndromes are at increased risk for developing pancreatic cancer. We prospectively evaluated the feasibility of screening for pancreatic neoplasia in high-risk individuals. Methods: Individuals from familial pancreatic cancer kindreds and a patient with Peutz-Jeghers syndrome underwent screening endoscopic ultrasound (EUS). If the EUS was abnormal, EUS-guided fine-needle aspiration, endoscopic retrograde cholangiopancreatography (ERCP), and spiral computed tomography (CT) were performed. Patients with abnormalities suggesting neoplasia had surgery. Results: Thirty-eight patients were studied; 31 (mean age, 58 yr; 42% men) from kindreds with ≥3 affected with pancreatic cancer; 6 from kindreds with 2 affected relatives, 1 was a patient with Peutz-Jeghers syndrome. None had symptoms referable to the pancreas or suggestive of malignancy. Six pancreatic masses were found by EUS: 1 invasive ductal adenocarcinoma, 1 benign intraductal papillary mucinous neoplasm, 2 serous cystadenomas, and 2 nonneoplastic masses. Hence, the diagnostic yield for detecting clinically significant pancreatic neoplasms was 5.3% (2 of 38). The 1 patient with pancreatic cancer was treated and still is alive and disease-free >5 years after surgery. EUS changes similar to those associated with chronic pancreatitis were found, which were more common in patients with a history of regular alcohol intake (P = 0.02), but also occurred in patients who did not consume alcohol. Screening also led to a new diagnosis and treatment of symptomatic upper-gastrointestinal conditions in 18.4% of patients. Conclusions: EUS-based screening of asymptomatic high-risk individuals can detect prevalent resectable pancreatic neoplasia but false-positive diagnoses also occur.

Original languageEnglish (US)
Pages (from-to)606-621
Number of pages16
JournalClinical Gastroenterology and Hepatology
Volume2
Issue number7
DOIs
StatePublished - Jul 2004

Fingerprint

Pancreatic Neoplasms
Neoplasms
Peutz-Jeghers Syndrome
Serous Cystadenoma
Alcohols
Endoscopic Ultrasound-Guided Fine Needle Aspiration
Spiral Computed Tomography
Endoscopic Retrograde Cholangiopancreatography
Chronic Pancreatitis
Pancreas
Adenocarcinoma

Keywords

  • computed tomography
  • CT
  • endoscopic retrograde cholangiopancreatography
  • endoscopic ultrasonography
  • ERCP
  • EUS
  • fine-needle aspiration
  • FNA
  • intraductal papillary mucinous neoplasm
  • IPMN
  • National Familial Pancreas Tumor Registry
  • NFPTR
  • PanIN

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Canto, M. I., Goggins, M., Yeo, C. J., Griffin, C., Axilbund, J. E., Brune, K., ... Hruban, R. H. (2004). Screening for pancreatic neoplasia in high-risk individuals: An EUS-based approach. Clinical Gastroenterology and Hepatology, 2(7), 606-621. https://doi.org/10.1016/S1542-3565(04)00244-7

Screening for pancreatic neoplasia in high-risk individuals : An EUS-based approach. / Canto, Marcia Irene; Goggins, Michael; Yeo, Charles J.; Griffin, Constance; Axilbund, Jennifer E.; Brune, Kieran; Ali, Syed Z.; Jagannath, Sanjay; Petersen, Gloria M; Fishman, Elliot K.; Piantadosi, Steven; Giardiello, Francis M.; Hruban, Ralph H.

In: Clinical Gastroenterology and Hepatology, Vol. 2, No. 7, 07.2004, p. 606-621.

Research output: Contribution to journalArticle

Canto, MI, Goggins, M, Yeo, CJ, Griffin, C, Axilbund, JE, Brune, K, Ali, SZ, Jagannath, S, Petersen, GM, Fishman, EK, Piantadosi, S, Giardiello, FM & Hruban, RH 2004, 'Screening for pancreatic neoplasia in high-risk individuals: An EUS-based approach', Clinical Gastroenterology and Hepatology, vol. 2, no. 7, pp. 606-621. https://doi.org/10.1016/S1542-3565(04)00244-7
Canto, Marcia Irene ; Goggins, Michael ; Yeo, Charles J. ; Griffin, Constance ; Axilbund, Jennifer E. ; Brune, Kieran ; Ali, Syed Z. ; Jagannath, Sanjay ; Petersen, Gloria M ; Fishman, Elliot K. ; Piantadosi, Steven ; Giardiello, Francis M. ; Hruban, Ralph H. / Screening for pancreatic neoplasia in high-risk individuals : An EUS-based approach. In: Clinical Gastroenterology and Hepatology. 2004 ; Vol. 2, No. 7. pp. 606-621.
@article{7e1633c318ff4529a18f7bba13cbe52d,
title = "Screening for pancreatic neoplasia in high-risk individuals: An EUS-based approach",
abstract = "Background & Aims: Relatives of patients with pancreatic cancer and persons with certain inherited syndromes are at increased risk for developing pancreatic cancer. We prospectively evaluated the feasibility of screening for pancreatic neoplasia in high-risk individuals. Methods: Individuals from familial pancreatic cancer kindreds and a patient with Peutz-Jeghers syndrome underwent screening endoscopic ultrasound (EUS). If the EUS was abnormal, EUS-guided fine-needle aspiration, endoscopic retrograde cholangiopancreatography (ERCP), and spiral computed tomography (CT) were performed. Patients with abnormalities suggesting neoplasia had surgery. Results: Thirty-eight patients were studied; 31 (mean age, 58 yr; 42{\%} men) from kindreds with ≥3 affected with pancreatic cancer; 6 from kindreds with 2 affected relatives, 1 was a patient with Peutz-Jeghers syndrome. None had symptoms referable to the pancreas or suggestive of malignancy. Six pancreatic masses were found by EUS: 1 invasive ductal adenocarcinoma, 1 benign intraductal papillary mucinous neoplasm, 2 serous cystadenomas, and 2 nonneoplastic masses. Hence, the diagnostic yield for detecting clinically significant pancreatic neoplasms was 5.3{\%} (2 of 38). The 1 patient with pancreatic cancer was treated and still is alive and disease-free >5 years after surgery. EUS changes similar to those associated with chronic pancreatitis were found, which were more common in patients with a history of regular alcohol intake (P = 0.02), but also occurred in patients who did not consume alcohol. Screening also led to a new diagnosis and treatment of symptomatic upper-gastrointestinal conditions in 18.4{\%} of patients. Conclusions: EUS-based screening of asymptomatic high-risk individuals can detect prevalent resectable pancreatic neoplasia but false-positive diagnoses also occur.",
keywords = "computed tomography, CT, endoscopic retrograde cholangiopancreatography, endoscopic ultrasonography, ERCP, EUS, fine-needle aspiration, FNA, intraductal papillary mucinous neoplasm, IPMN, National Familial Pancreas Tumor Registry, NFPTR, PanIN",
author = "Canto, {Marcia Irene} and Michael Goggins and Yeo, {Charles J.} and Constance Griffin and Axilbund, {Jennifer E.} and Kieran Brune and Ali, {Syed Z.} and Sanjay Jagannath and Petersen, {Gloria M} and Fishman, {Elliot K.} and Steven Piantadosi and Giardiello, {Francis M.} and Hruban, {Ralph H.}",
year = "2004",
month = "7",
doi = "10.1016/S1542-3565(04)00244-7",
language = "English (US)",
volume = "2",
pages = "606--621",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "7",

}

TY - JOUR

T1 - Screening for pancreatic neoplasia in high-risk individuals

T2 - An EUS-based approach

AU - Canto, Marcia Irene

AU - Goggins, Michael

AU - Yeo, Charles J.

AU - Griffin, Constance

AU - Axilbund, Jennifer E.

AU - Brune, Kieran

AU - Ali, Syed Z.

AU - Jagannath, Sanjay

AU - Petersen, Gloria M

AU - Fishman, Elliot K.

AU - Piantadosi, Steven

AU - Giardiello, Francis M.

AU - Hruban, Ralph H.

PY - 2004/7

Y1 - 2004/7

N2 - Background & Aims: Relatives of patients with pancreatic cancer and persons with certain inherited syndromes are at increased risk for developing pancreatic cancer. We prospectively evaluated the feasibility of screening for pancreatic neoplasia in high-risk individuals. Methods: Individuals from familial pancreatic cancer kindreds and a patient with Peutz-Jeghers syndrome underwent screening endoscopic ultrasound (EUS). If the EUS was abnormal, EUS-guided fine-needle aspiration, endoscopic retrograde cholangiopancreatography (ERCP), and spiral computed tomography (CT) were performed. Patients with abnormalities suggesting neoplasia had surgery. Results: Thirty-eight patients were studied; 31 (mean age, 58 yr; 42% men) from kindreds with ≥3 affected with pancreatic cancer; 6 from kindreds with 2 affected relatives, 1 was a patient with Peutz-Jeghers syndrome. None had symptoms referable to the pancreas or suggestive of malignancy. Six pancreatic masses were found by EUS: 1 invasive ductal adenocarcinoma, 1 benign intraductal papillary mucinous neoplasm, 2 serous cystadenomas, and 2 nonneoplastic masses. Hence, the diagnostic yield for detecting clinically significant pancreatic neoplasms was 5.3% (2 of 38). The 1 patient with pancreatic cancer was treated and still is alive and disease-free >5 years after surgery. EUS changes similar to those associated with chronic pancreatitis were found, which were more common in patients with a history of regular alcohol intake (P = 0.02), but also occurred in patients who did not consume alcohol. Screening also led to a new diagnosis and treatment of symptomatic upper-gastrointestinal conditions in 18.4% of patients. Conclusions: EUS-based screening of asymptomatic high-risk individuals can detect prevalent resectable pancreatic neoplasia but false-positive diagnoses also occur.

AB - Background & Aims: Relatives of patients with pancreatic cancer and persons with certain inherited syndromes are at increased risk for developing pancreatic cancer. We prospectively evaluated the feasibility of screening for pancreatic neoplasia in high-risk individuals. Methods: Individuals from familial pancreatic cancer kindreds and a patient with Peutz-Jeghers syndrome underwent screening endoscopic ultrasound (EUS). If the EUS was abnormal, EUS-guided fine-needle aspiration, endoscopic retrograde cholangiopancreatography (ERCP), and spiral computed tomography (CT) were performed. Patients with abnormalities suggesting neoplasia had surgery. Results: Thirty-eight patients were studied; 31 (mean age, 58 yr; 42% men) from kindreds with ≥3 affected with pancreatic cancer; 6 from kindreds with 2 affected relatives, 1 was a patient with Peutz-Jeghers syndrome. None had symptoms referable to the pancreas or suggestive of malignancy. Six pancreatic masses were found by EUS: 1 invasive ductal adenocarcinoma, 1 benign intraductal papillary mucinous neoplasm, 2 serous cystadenomas, and 2 nonneoplastic masses. Hence, the diagnostic yield for detecting clinically significant pancreatic neoplasms was 5.3% (2 of 38). The 1 patient with pancreatic cancer was treated and still is alive and disease-free >5 years after surgery. EUS changes similar to those associated with chronic pancreatitis were found, which were more common in patients with a history of regular alcohol intake (P = 0.02), but also occurred in patients who did not consume alcohol. Screening also led to a new diagnosis and treatment of symptomatic upper-gastrointestinal conditions in 18.4% of patients. Conclusions: EUS-based screening of asymptomatic high-risk individuals can detect prevalent resectable pancreatic neoplasia but false-positive diagnoses also occur.

KW - computed tomography

KW - CT

KW - endoscopic retrograde cholangiopancreatography

KW - endoscopic ultrasonography

KW - ERCP

KW - EUS

KW - fine-needle aspiration

KW - FNA

KW - intraductal papillary mucinous neoplasm

KW - IPMN

KW - National Familial Pancreas Tumor Registry

KW - NFPTR

KW - PanIN

UR - http://www.scopus.com/inward/record.url?scp=3042525898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042525898&partnerID=8YFLogxK

U2 - 10.1016/S1542-3565(04)00244-7

DO - 10.1016/S1542-3565(04)00244-7

M3 - Article

C2 - 15224285

AN - SCOPUS:3042525898

VL - 2

SP - 606

EP - 621

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 7

ER -